These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 30793410)
21. Somatic symptoms disorders in Parkinson's disease are related to default mode and salience network dysfunction. Franciotti R; Delli Pizzi S; Russo M; Carrarini C; Carrozzino D; Perfetti B; Onofrj M; Bonanni L Neuroimage Clin; 2019; 23():101932. PubMed ID: 31491814 [TBL] [Abstract][Full Text] [Related]
22. Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study. Mestre TA; Pont-Sunyer C; Kausar F; Visanji NP; Ghate T; Connolly BS; Gasca-Salas C; Kern DS; Jain J; Slow EJ; Faust-Socher A; Kasten M; Wadia PM; Zadikoff C; Kumar P; de Bie RM; Thomsen T; Lang AE; Schüle B; Klein C; Tolosa E; Marras C Mov Disord; 2018 Jul; 33(6):960-965. PubMed ID: 29665080 [TBL] [Abstract][Full Text] [Related]
23. Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation. Matikainen-Ankney BA; Kezunovic N; Mesias RE; Tian Y; Williams FM; Huntley GW; Benson DL J Neurosci; 2016 Jul; 36(27):7128-41. PubMed ID: 27383589 [TBL] [Abstract][Full Text] [Related]
24. The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study. Liu SY; Wile DJ; Fu JF; Valerio J; Shahinfard E; McCormick S; Mabrouk R; Vafai N; McKenzie J; Neilson N; Perez-Soriano A; Arena JE; Cherkasova M; Chan P; Zhang J; Zabetian CP; Aasly JO; Wszolek ZK; McKeown MJ; Adam MJ; Ruth TJ; Schulzer M; Sossi V; Stoessl AJ Lancet Neurol; 2018 Apr; 17(4):309-316. PubMed ID: 29456161 [TBL] [Abstract][Full Text] [Related]
25. Changes in functional organization and white matter integrity in the connectome in Parkinson's disease. Tinaz S; Lauro PM; Ghosh P; Lungu C; Horovitz SG Neuroimage Clin; 2017; 13():395-404. PubMed ID: 28116232 [TBL] [Abstract][Full Text] [Related]
26. The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies. Pont-Sunyer C; Tolosa E; Caspell-Garcia C; Coffey C; Alcalay RN; Chan P; Duda JE; Facheris M; Fernández-Santiago R; Marek K; Lomeña F; Marras C; Mondragon E; Saunders-Pullman R; Waro B; Mov Disord; 2017 May; 32(5):726-738. PubMed ID: 28370517 [TBL] [Abstract][Full Text] [Related]
27. Clinical profiles associated with LRRK2 and GBA mutations in Brazilians with Parkinson's disease. da Silva CP; de M Abreu G; Cabello Acero PH; Campos M; Pereira JS; de A Ramos SR; Nascimento CM; Voigt DD; Rosso AL; Araujo Leite MA; Vasconcellos LFR; Nicaretta DH; Della Coletta MV; da Silva DJ; Gonçalves AP; Dos Santos JM; Calassara V; Valença DCT; de M Martins CJ; Santos-Rebouças CB; Pimentel MMG J Neurol Sci; 2017 Oct; 381():160-164. PubMed ID: 28991672 [TBL] [Abstract][Full Text] [Related]
28. Gender-specific effect of uric acid on resting-state functional networks in de novo Parkinson's disease. Lee Y; Park YH; Lee JJ; Sohn YH; Lee JM; Lee PH Parkinsonism Relat Disord; 2018 Jul; 52():49-54. PubMed ID: 29606606 [TBL] [Abstract][Full Text] [Related]
29. Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers. Pachi I; Koros C; Simitsi AM; Papadimitriou D; Bougea A; Prentakis A; Papagiannakis N; Bozi M; Antonelou R; Angelopoulou E; Beratis I; Stamelou M; Trapali XG; Papageorgiou SG; Stefanis L Parkinsonism Relat Disord; 2021 Oct; 91():1-8. PubMed ID: 34425330 [TBL] [Abstract][Full Text] [Related]
30. Investigating Voice as a Biomarker for Leucine-Rich Repeat Kinase 2-Associated Parkinson's Disease. Arora S; Visanji NP; Mestre TA; Tsanas A; AlDakheel A; Connolly BS; Gasca-Salas C; Kern DS; Jain J; Slow EJ; Faust-Socher A; Lang AE; Little MA; Marras C J Parkinsons Dis; 2018; 8(4):503-510. PubMed ID: 30248062 [TBL] [Abstract][Full Text] [Related]